Amelia B Zelnak1, Ruth M O'Regan. Show Affiliations » 1. Winship Cancer Institute at Emory University School of Medicine, USA.
Abstract
Entities: Disease
Mesh： See more » Anticarcinogenic Agents/therapeutic useAromatase InhibitorsBreast Neoplasms/prevention & controlChemopreventionClinical Trials as TopicCyclooxygenase Inhibitors/therapeutic useEnzyme Inhibitors/therapeutic useFemaleHumansRaloxifene Hydrochloride/therapeutic useRisk FactorsSelective Estrogen Receptor Modulators/therapeutic useTamoxifen/therapeutic use
Substances： See more » Anticarcinogenic AgentsAromatase InhibitorsCyclooxygenase InhibitorsEnzyme InhibitorsSelective Estrogen Receptor ModulatorsTamoxifenRaloxifene Hydrochloride
Year: 2004 PMID： 15318323 DOI： 10.1016/j.currproblcancer.2004.05.007
Source DB: PubMed Journal: Curr Probl Cancer ISSN： 0147-0272 Impact factor: 3.187